Please Note: The Conference Program below is not in its final version, adjustments will occur. Final Program will be available two months before the conference date.
World Congress of Vaccine-2012
Theme: Innovations Accelerating Vaccine Development
Dr. Yan Chen, Senior Vice President, Antibody Research, X-BODY BioSciences, USA
09:10-09:40
Title: Technology and Process Evolutions in Vaccines Dr. Rene Labatut,Vice President Global Manufacturing Technology, Sanofi Pasteur Inc., France
09:40-10:10
Title: Novel Antibodies for Respiratory and Autoimmune Diseases Dr. Zhengbin (Bing) Yao, Senior Vice President, MedImmune, USA
10:10-10:40
Title: From Treatment to Prevention: The Paradigm Going Forward Dr. Raymond E. Spier,President, The International Society for Vaccines, UK
10:40-11:10
Title: Antibody Mediated Cellular Immunotherapy for Cancer Dr. Yajun Guo, Professor, Second Military Medical University, China
11:10-11:40
Title: Higher Efficiencies - Fewer B Cells: An Optimized Protocol for Maximizing mAb Yields Dr. Robin E. Butler, Business Development Manager, BTX Harvard Apparatus, USA
Dr. A. M. Palache, Global Government Affairs Director, Vaccines, Abbott Biologicals, The Netherlands
Co-Chair
Dr. Erich Hugo Cerny, CSO, Chilka Limited, Switzerland
13:30-13:55
Title: Vaccine Innovation: Challenges and Opportunities in the Brazilian Experience Dr. Rosiceli Barreto G. Baetas, Advisor to the Vice President of Productuon and Innovation, Oswaldo Cruz Foundation/Ministry of Healh, Brazil
13:55-14:20
Title: Vaccines against Drugs of Abuse Dr. Erich Hugo Cerny, CSO, Chilka Limited, Switzerland
14:20-14:45
Title:Pandemic Preparedness and seasonal influenza immunization: Opportunities and Challenges for Public Health Dr. A. M. Palache, Global Government Affairs Director, Vaccines, Abbott Biologicals, The Netherlands
14:45-15:10
Title: New Aspects of Chemotherapy of Enveloped Viruses Using the Example of Influenza and Measles Viruses Dr. Nadezda Yuminova, Chairman of Problem Commission, Fundamental Vaccinology Russian Academy of Medical Sciences, Russia
15:10-15:30
Coffee Break
15:30-15:55
Title: Bacterial Spore Forming Organisms: Impact of Basic Biology of Vaccine Development Dr. Adam Driks, Associate Professor, Loyola University, USA
15:55-16:20
Title: The Norovirus P Domain Complexes as Versatile Platforms for Antigen Presentation for Dual Vaccine Development Dr. Ming Tan, Assistant Professor,Cincinnati Children's Hospital Medical Center, USA
16:20-16:45
Title: Problem of Measles Eradication in Ukraine Dr. Moiseieva Anna, Doctor of Medical Science, State Expert Centre MoH, Ukraine
16:45-17:10
Title: Highlighting Delays in Childhood Immunization in Low-income Countries: Example from a Study in Sierra Leone, West Africa Dr. Charles Edward Lahai Senessie, Founder & President, Afro-European Medical and Research Network, Switzerland
Session 1-2: Effectiveness and Safety Evaluation of Vaccines, New Vaccine Economy, Safety, Ethic Issues, and Public Acceptance
Dr. Guang Zeng, Professor, Chinese Center for Disease Control and Prevention (China CDC), China
13:30-13:50
Title: Pneumococcal Anti-capsular IgG Concentrations in Chinese Children Previously Vaccinated with PCV7, PCV7+DTaP or DTaP Alone Dr. Mariano Young Jr.,Director, Vaccine Clinical Research, Pfizer Inc, China
13:50-14:10
Title: Prevention of Children Pneumococcal Disease Dr. Guang Zeng, Professor, Chinese Center for Disease Control and Prevention (China CDC), China
14:10-14:30
Title: Vaccine Refusal in Seattle, USA Dr.Hervey Froehlich, Medical Center Chief, Group Health Physicians, USA
14:30-14:50
Title: Vaccination - Effectiveness and Public Acceptance in Latvia Dr. Ludmila Viksna, Professor & Chief, Riga Stradins University, Latvia
14:50-15:10
Title:The Application of Tetramer Technology in Vaccine Development Dr. Weihong Zhang, Vice President, Quantobio, Inc., China��
Dr. Ruobing Wang, Associate Professor, University of Washington, USA
13:30-13:50
Keynote Speech: Title: Complex Systems Basis of the Autoimmune Response: Teleological Principles Affect Hierarchy of Host Agent Interfaces to Enhance Vaccine Development Dr. Richard L. Amoroso, Professor & Director, Noetic Advanced Studies Institute, USA
13:50-14:10
Title: Rational Design of a Fully Synthetic Nanoparticle-based Vaccine for Smoking Cessation Dr. Takashi Kei Kishimoto, Chief Scientific Officer, Selecta Biosciences, USA
14:10-14:30
Title: Influenza Genome Heteroduplex Interactions are the Key Event in Genetic Variability and Host
Adaptation Process
Dr. Vladimir Mikhailovich Blinov, Chief, Panagen Ltd., Russia
14:30-14:50
Title: Species-specific Activation of Toll-like Receptor 9 by Immunostimulatory CpG-ODN Dr. Tsung-Hsien Chuang, Associate Investigator, Immunology Research Center, National Health Research Institutes, Taiwan
14:50-15:10
Title: Immune Signatures of Protection Induced by Whole Parasite Malaria Vaccines Dr. Ruobing Wang, Associate Professor, University of Washington, USA
15:10-15:30
Coffee Break
15:30-15:50
Title: Immunotherapy of MHC Class I-deficient Tumoursand Epigenetic Mechanisms in Tumour Cell Escape from Immune Response Dr. Milan Reinis, Head, Institute of Molecular Genetics, Czech Republic
15:50-16:10
Title: Vaccinomics- Applications in Natural Compound Dr. Ernesto Torres-Lopez, Professor & Researcher, Medicine School, Universidad Autonoma de Nuevo Leon, Mexico
16:10-16:30
Title: Nasal Delivery of Japanese Encephalitis Vaccine Using Chitosan and Al(OH)3 Coated Poly(D,L lactic-co-glycolic acid) Microparticles as Adjuvants
Dr. Garnpimol C. Ritthidej, Professor, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Thailand
16:30-16:50
Title: Sequential H1N1 Infections Elicit Cross-Reactive Antibodies Against Emerging Pandemic H1N1 Influenza Viruses Dr. Donald M. Carter, Senior Researcher, University of Pittsburgh, USA
16:50-17:10
Title: P Particle Mucosal Vaccine Induced Stronger Th1 and HBGA-Binding Blocking Antibody Responses than Norovirus Infection in Gnotobiotic Pigs Dr. Lijuan Yuan, Assistant Professor, Virginia Polytechnic Institute and State University, USA
17:10-17:30
Title: How Much Stimulation does a T cell Need - Affinity Thresholds for T cell Activation Dr. Dietmar Zehn, �Assistant Professor, Swiss Vaccine Research Institute, Centre Hospitalier Universitaire Vaudois / Division of Immunology and Allergy, Switzerland
Session 2-2: Structure-based Antigen Design and Animal Models for Vaccine Development
Dr. Nathalie Garcon, Vice President, GlaxoSmithKline Biologicals, Belgium
Co-Chair:
Dr. Dieter Klein, Professor, University of Veterinary Medicine, Austria
08:30-08:55
Title:Feline Immunodeficiency Virus as a Natural Animal Model for HIV Vaccine Research: Advantages and Limitations Dr. Dieter Klein, Professor, University of Veterinary Medicine, Austria
08:55-09:20
Title: Biosafety Management at a Centre for Clinical and Experimental Infection Research � From Concept to Practice Dr. Juergen Mertsching,Head, The Biological Safety Department, Hannover Medical School, Germany
09:20-09:45
Title: Promising Strategies for Designing Multi-T-lymphocyte Epitope Based Synthetic DNA Vaccine Dr. Sergei I. Bazhan, Professor, State Research Center of Virology and Biotechnology Vector, Russia
09:45-10:10
Title:Structure-based Design of Influenza a Virus Hem Agglutinin Subtype-specific Subunit Vaccines Dr. Haixia Xiao, Associate Professor, Tianjin Institute of Industrial Biotechnology, CAS, China
Dr. Ingmar Hoerr, Chief Executive Officer, CureVac GmbH, Germany
Co-Chair:
Dr. Ted M. Ross, Associate Professor, University of Pittsburgh, USA
13:30-13:55
Title: Potent Novel mRNA based Vaccines and Adjuvants Dr. Ingmar Hoerr, Chief Executive Officer, CureVac GmbH, Germany
13:55-14:20
Title: Bacterial Enteric Infections Control by Vaccination with Polysaccharide Vaccines: Strategy of Mass-vaccination against Typhoid Fever and Shigella sonnei Shigellosis in Russian Federation Dr. Petr G. Aparin, Head of Carbohydrate Vaccine Lab, National Research Center, Institute of Immunology, Russia
14:20-14:45
Title: Safety, Costs, Efficiency, Impact of Vaccination - Role of Health Technology Assessments (HTA) around the World Dr. Aleksandra Kucharczyk,Associated Professor, Department of Allergology and Clinical Immunology, Poland
14:45-15:10
Title: Computationally Optimized Broadly Reactive Antigen (COBRA): A Novel Strategy for Developing a Broadly Reactive Vaccine Against Emerging Influenza Viruses Dr. Ted M. Ross, Associate Professor, University of Pittsburgh, USA
15:10-15:30
Coffee Break
15:30-15:55
Title: Green Vaccine Factories to Curb Deadly Poultry Viral Diseases Dr. Sandy Hwei-San Loh, Associate Professor, University of Nottingham, Malaysia
15:55-16:20
Title: The Production of Oral Vaccines in Plants and Microalgae: Aspects, Potentials and Challenges Dr. Hamid Rajabi Memari, Assistant Professor, Shahid Chamran University of Ahvaz, Iran
Dr. Kathleen L. Hefferon, Professor, University of Toronto, Canada
08:30-08:55
Title: The Mucosal Immmune Response to Plant-Derived Vaccines Dr. Kathleen L. Hefferon, Professor, University of Toronto, Canada
08:55-09:20
Title: The Bacterial Ghost Platform as a Functional Vaccine Delivery System Dr. Francis O. Eko, Professor, Morehouse School of Medicine, USA
09:20-09:45
Title:Novel Vaccination Regimens Based on Heterologous Prime-boost and Encoded Adjuvants Dr. Riccardo Cortese, CEO, Okairos, Italy
09:45-10:10
Title:New Adjuvant Application for DNA Vaccine�Praziquantel Facilitates Tc1 and Tc17 Responses to DNA Vaccination Dr. Bin Wang, Professor, Fudan University Shanghai Medical College, China
10:10-10:30
Coffee Break
10:30-10:55
Title: Selection of Protein Targets for a Subunit Vaccine against Contagious Bovine Pleuropneumonia Dr. Anja Persson,Project Director, Royal Institute of Technology, Sweden
10:55-11:20
Title: Intranasal Immunization of Japanese Encephalitis (JE) Vaccine Using Chitosan and Its Derivative as Adjuvants Dr. Tasana Pitaksuteepong, Associate Professor, Naresuan University, Thailand
11:20-11:45
Title: Lipid Antigens as Novel Components of Subunit Tuberculosis Vaccines Dr. Gennaro De Libero, Professor, University of Basel Director Tuberculosis Program, Singapore Immunology Network (SIgN) A-STAR, Singapore
Session 3-2: Recombinant Vector Vaccines,Glycoconjugate Vaccines and Peptide Vaccines
Dr. Michael Wacker, Chief Scientific Officer, GlycoVaxyn AG, Swizerland
Co-Chair:
Dr. Jude E Uzonna, Associate Professor, University of Manitoba, Canada
08:30-08:55
Title: Vaccine Applications for N-glycoproteins Produced in E. coli Dr. Michael Wacker, Chief Scientific Officer, GlycoVaxyn AG, Swizerland
08:55-09:20
Title: The Creation of Clostridium Difficile and ETEC Glycoconjugate Vaccines Dr. Mario A. Monteiro,Professor, University of Guelph, Canada
Presenter: Mr. Jiao Yuening, PHD, University of Guelph, Canada
09:20-09:45
Title: Flunisyn, Advanced Development of a Synthetic Universal Influenza T-cell Vaccine
Dr.Bertrand Georges, Co-Founder, Immune Targeting Systems (ITS) Ltd., UK
09:45-10:10
Title: Use of Immuno-Proteomics to Identify Immunogenic Peptides that Elicit Protective Immunity Dr. Jude E Uzonna, Associate Professor,University of Manitoba, Canada
10:10-10:30
Coffee Break
10:30-10:55
Title: Computer-aided Discovery of Immunogenic Epitopes for Peptide Vaccine Development
Dr. Lawrence JK Wee, Research Scientist, Institute for Infocomm Research, Singapore
10:55-11:20
Title: Preclinical Evaluation of a Novel Recombinant Chlamydial Vaccine Dr. Qing He, Assistant Professor, Morehouse School of Medicine, USA
11:20-11:45
Title: Novel Strategies to Develop Bacterial Vector Vaccine Based on in Vivo Inducible Lysis System
Dr. Jingfan Xiao, Associate Professor, EastChinaUniversity of Science and Technology, China
11:45-12:10
Title: Human Papilloma Virus Vaccine - Its Safety and Side Effects Dr.Somsubhra De, Assistant Professor, Melaka Manipal Medical College, Malaysia
Dr. Paolo Morazzoni, Scientific Director, Indena S.p.A., Italy
08:30-08:55
Title: A New Anti-ErbB-2 Chimeric Vaccine: From Discovery to the Patient Dr. Paolo Morazzoni, Scientific Director, Indena S.p.A., Italy
08:55-09:20
Title: Melanoma Peptide Vaccines Dr. Aaron S. Mansfield, Clinician Investigator,Department of Medicine, Mayo Clinic, USA
09:20-09:45
Title: ImmunoBodyTM DNA Cancer Vaccination with T Cell Epitopes Incorporated within Antibody Vectors Stimulates High Avidity Tumour Specific Immune Responses Dr. Wei Xue, Research Scientist, Scancell Ltd, UK
09:45-10:10
Title: Screening of B Cell Epitopes and Vaccination with Peptide-CpG-DNA-liposome Complex without Carriers Dr. Younghee Lee, Associate Professor, Department of Biochemistry, College of Natural Sciences, Chungbuk National University, South Korea
10:10-10:30
Coffee Break
Session 4-2: Emerging Prophylactic Adult Vaccine R & D
Title: Modified Vaccinia Virus Ankara (MVA) as a Viral Vector for New Vaccines Dr. Teoh Yee Leong, Vice President, Vaccine Development at Emergent Biosolutions (EBS),� Singapore
11:10-11:30
Title: Vaccines against Yersinia Pestis (Plague) Dr. Vladimir Motin, Associate Professor, University of Texas Medical Branch, USA
11:30-11:50
Title: Prevalence of Human Papillomavirus Infections among Patients with Invasive Cervical Cancer Dr. Sharifa Ezat, Associate Professor, Faculty of Medicine, National University, Malaysia
Dr. Leonard P. Ruiz, President, International Medica Foundation, USA
Co-Chair:
Dr. Kelly T. McKee, Vice President, Public Health and Government Services, Quintiles Transnational Corporation, USA
13:30-13:55
Title: A Strategy for Addressing Intussusception Associated with Rotavirus Vaccines Dr. Leonard P. Ruiz, President, International Medica Foundation, USA
13:55-14:20
Title: Development and Utilization of a Live-attenuated Vaccine against Argentine Hemorrhagic Fever Dr. Kelly T. McKee, Vice President, Public Health and Government Services, Quintiles Transnational Corporation, USA
14:20-14:45
Title: Evaluation of Humoral Immunity of Varicella Vaccinated Korean Children Using Fluorescent Antibody to Membrane Antigen Test and Commercial gpEIA Dr. Ho Sun Park, Professor, College of Medicine, Yeungnam University, South Korea
14:45-15:10
Title: Early Measles Vaccination to Non-Infected Babies of HIV-infected Mothers Dr. Lars Smedman, Associate Professor, Karolinska Institute, Sweden
15:10-15:30
Coffee Break
15:30-15:55
Title: Nurses Influenza Vaccination Behaviours and Influencing Factors: Findings from a London Survey of Registered Nurses Dr. Jing Zhang, Associate Professor, Second Military Medical University, China
15:55-16:20
Title: Plant-based Oral Hepatitis B Vaccine in Tablet Form: Biological and Immunological Feasibility Study Dr. Jozef Kapusta, Assistant Professor, Institute of Biotechnology and Antibiotics, Poland
16:20-16:45
Title: A Potential Drug Target for Treating Prion Diseases Dr. Jiapu Zhang, Research Scientist, The University of Ballarat, Australia
16:45-17:10
Title: Immune Repertoire Profiling by High Throughput Sequencing Dr. Jiankui He, Postdoctoral Research Fellow, Stanford University, USA
17:10-17:35
Title: Hantaviruses Infection among Rodents, Insectivores and Human in the Archipelago of Indonesia
Dr. Ima Nurisa Ibrahim, Veterinarion, National Institute of Health Research and Development, Ministry of Health, Indonesia
Session 4-4: Vaccine Development against Klebsiella and Streptococcus Pneumoniae
Dr.Sheau-Mei Cheng, Senior Program Officer, Pneumococcal Vaccine Project, PATH, USA
13:30-13:55
Title: Development of Pneumococcal Conjugate Vaccines Dr.Sheau-Mei Cheng, Senior Program Officer, Pneumococcal Vaccine Project, PATH, USA
13:55-14:20
Title: Application of Metabolome and Proteome Analysis to Decipher Novel Pneumococcal Vaccines Candidates Dr. Sven Hammerschmidt, Professor, Interfaculty Institute for Genetics and Functional Genomics, University of Greifswald, Germany
14:20-14:45
Title: Streptococcus Pneumoniae Pep27 Mutant as a Mucosal Vaccine Dr. Dong-Kwon Rhee, Professor, Sungkyunkwan University, South Korea
14:45-15:10
Title: The Impact of Pneumococcal-conjugate Vaccine-7 on Pneumococcal Disease Burden in Kuwait: New Serotypes and Antimicrobial Resistance Challenge Dr. Eiman M A Mokaddas, Professor; Chairman, Kuwait University, Kuwait
15:10-15:30
Coffee Break
Session 4-5: Vaccine against Shigellosis, Enterotoxigenic E. Coli (ETEC), and Uropathogenic Escherichia Coli
Dr. Richard Ives Walker, Director, Enteric Vaccine Initiative, Vaccine Development Global Program, PATH, USA
15:30-15:50
Title: New Possibilities for ETEC and Shigella Vaccines Dr. Richard Ives Walker, Director, Enteric Vaccine Initiative, Vaccine Development Global Program, PATH, USA
15:50-16:10
Title: The Case for Investment in ETEC Vaccines
Dr.A. Louis Bourgeois, ETEC Science Officer, Enteric Vaccine Initiative, PATH, USA
16:10-16:30
Title: Iron Acquisition Systems as Targets for Vaccination against Uropathogenic E. coli Dr. Harry L.T. Mobley, Professor; Chair, Department of Microbiology and Immunology, University of Michigan Medical School, USA
16:30-16:50
Title: ACE527 an Oral Live Attenuated ETEC Vaccine Reduces the Incidence and Severity of Disease In a Phase II Human Challenge Trial Dr. Michael J Darsley, Consultant, Enteric Vaccine Initiative, PATH, USA
16:50-17:10
Title: On the Road to a Synthetic Carbohydrate-based Vaccine against Endemic Shigellosis: Shigella Flexneri Serotype 2a as an Example Dr. Laurence A. Mulard, Head, Institut Pasteur, France
Dr. Edgar M Carvalho, Professor, Federal University of Bahia, Brazil
10:30-10:55
Title: Challenge in Vaccine Development for Leishmaniasis Dr. Edgar M Carvalho, Professor, Federal University of Bahia, Brazil
10:55-11:20
Title: Novel Expression and mRNA Sequence Detection of Schistosoma mansoni Cathepsin L1 in Egypt; Suggesting Potential Target for Chemotherapy and Vaccine Development Dr. Suher Zada, Professor, American University in Cairo, Egypt
11:20-11:45
Title: Prospect Antigens for Vaccination against Schistosoma mansoni and Toxoplasma gondii Parasitic Infections in Endemic Areas Dr. Hisham Ismail Mohamed Osman, Associate Professor, Umm Al-Qura University, Saudi Arabia
Dr. Andrew A. Potter, Director; CEO, VIDO / InterVac, Canada
08:30-08:55
Title: New Vaccine Approach for the Control of Avian Influenza Using rHVT Vector Technology Dr. Yannick Gardin, Director, Ceva Sante Animale, France
08:55-09:20
Title:Platform Technologies for Veterinary Vaccines Dr. Andrew A. Potter, Director; CEO, VIDO/InterVac, Canada
09:20-09:45
Title: Montanide Companion Animal Adjuvant for Long-term Immune Response in Dog Rabies Vaccine Dr. Francois Bertrand, Asia Pacific Technical Development & Marketing Manager, SEPPIC, China
09:45-10:10
Title: Economically Viable, Scalable, and Stable Formulations for Oral Delivery of Animal Vaccines Dr. Juan J. Infante, Chief Scientific Officer, Bioorganic Research and Services, S.A. (Bionaturis)., Spain
10:10-10:30
Coffee Break
10:30-10:55
Title: An Elastase-dependent Attenuated Heterologous Swine Influenza Virus Protects against Pandemic H1N1 2009 influenza Challenge in Swine Dr. Shawn L Babiuk, Research Scientist, Canadian Food Inspection Agency, Canada
10:55-11:20
Title: Peste Des Petits Ruminants Virus: New Approaches with Old Vaccines Dr. Ashley C. Banyard, Senior Scientist, The Animal Health and Veterinary Laboratories Agency (AHVLA), UK
11:20-11:45
Title:An Overview of the Scope of R&D in VSVRI
Dr. Seham El-Zeedy, Professor, Veterinary Serum & Vaccine Research Institute, Egypt
11:45-12:10
Title: Poultry Vaccine to Reduce Public Health Risks Dr. Hiroaki Ohta, Senior Adviser, CAF Laboratories Inc., Japan
12:10-12:35
Title: Vaccine Potential of Deletion Variants of Epsilon Toxin of Clostridium Perfringens
Dr. Lalit C. Garg, Staff Scientist, National Institute of Immunology, India
Session 5-2: Introduction to New Generation of Veterinary Vaccines
Dr.Zhen F. Fu, Professor, Department of Pathology, University of Georgia, USA
Co-Chair:
Dr. Hsien-Jue Steve Chu, Vice President, Global Biology Research and Development, Ceva Sante Animale, USA
08:30-08:55
Keynote Speech: Title: Vaccination against Foot-and-Mouth Disease Virus: Strategies and Effectiveness Dr. Satya Parida, Professor & Head, FMD Vaccine Differentiation, Institute for Animal Health, UK
08:55-09:20
Title:Developing Live Avirulent Rabies Virus Vaccines for Animals and Humans Dr.Zhen F. Fu, Professor, Department of Pathology, University of Georgia, USA
09:20-09:45
Title: Development of A Novel Oral Vaccine Using Transgenic Yeast against Porcine Pleuropneumonia Dr. Han Sang Yoo, Professor, Seoul National University, South Korea
09:45-10:10
Title: Improving DNA Vaccine Delivery and Efficacy in Poultry Dr. Abdul Rahman Omar, Professor, Institute of Bioscience, Universiti Putra Malaysia, Malaysia
10:10-10:30
Coffee Break
10:30-10:55
Title: Montanide Adjuvants for Mucosal Application of Live Avian Vaccines Dr. Lillian Han, China AVI and Pharmacy Business Development Manager, SEPPIC, China
10:55-11:20
Title: Experimental Studies on Whole Bee Venom Inactivated Rift Valley Fever Vaccine Candidate in Vitro and in Some Laboratory Animals Dr. Samia Ahmed Kamal, Researcher, Animal Health Research Institute(AHRI), Egypt
11:20-11:45
Title: Introducing Basic Aspects of Antigens from Midgut of Ticks (Acari: Ixodidae) and Challenge data of Vaccinated Cattle When Infested with Laboratory- bred Boophilus Annulatus, Iranian Strain Dr. Mohammad Abdigoudarzi, Assistant Professor, Razi Vaccine and Serum Research Institute, Iran
Session 5-3: Antiviral and Antibacterial Fish Vaccines
Dr. Ronald L. Thune, Professor, Louisiana State University School of Veterinary Medicine, USA
Co-Chair:
Dr. Kjersti Gravningen, Director, PHARMAQ Vietnam Co. Ltd, Norway
15:30-15:55
Title: The Status and Impact of Fish Vaccines, Trends Forward Dr. Kjersti Gravningen, General Director, PHARMAQ Vietnam Co. Ltd, Norway
15:55-16:20
Title: Towards the Intelligent Design of a Vaccine against Edwardsiella Ictaluri Dr. Ronald L. Thune, Professor, Louisiana State University School of Veterinary Medicine, USA
16:20-16:45
Title: Bacterial Fish Vaccines - Development, Production and Use Dr. Abdullah S. Madhun, Leader of Research Group, Institute of Marine Research, Norway
16:45-17:10
Title: Vaccination Strategies in Aquaculture with Emphasis on Atlantic Salmon Production Dr. Atle Lillehaug, Fish Health Expert, Norwegian Veterinary Institute, Norway
Dr. Ming-Hsiao Chan, Researcher & Team Leader, Division of Clinical Science, Center for Drug Evaluation, Taiwan
13:30-13:55
Title: The Considerations of Early Phase Vaccine Clinical Trials from Regulatory Perspective Dr. Ming-Hsiao Chan, Researcher & Team Leader, Division of Clinical Science, Center for Drug Evaluation, Taiwan
13:55-14:20
Title: Clinical Research in Vaccinology: Difficulties in Defining Efficacy Endpoints Dr. Jakob P. Cramer, Expert, Section Tropical Medicine, University Medical Center Hamburg-Eppendorf, Germany
14:20-14:45
Title: Statistical Methods in Estimating Vaccine Efficacy Dr. Xuan Chen, Senior Statistician, Sanofi Pasteur (Biometry China), China
14:45-15:10
Title: A Quantitative Evaluation of Alphavbeta3 Endometrial Integrin of Fertile and Unexplained Infertile Women during the Menstrual Cycle by Immunoradiometricassay Mr.Alphonse Tshiband Tshitsh, Scientist Biomedical & Head, Nuclear Research Center of Kinshasa, Democratic Republic of the Congo
15:10-15:30
Coffee Break
15:30-15:55
Title: Methodology, Results and Lessons-learned from the Phase I to IV Clinical Trials of the Rotavirus Vaccines in Bangladesh Dr. Md. Khalequzzaman, Senior Scientist, International Centre for Diarrhoeal Disease Research, Bangladesh
15:55-16:20
Title: Ensuring Participants Safety in a First in Man Vaccine Clinical Trial Dr. Nabil Al-Tawil, Consultant Physician, Karolinska University Hospital, Sweden
16:20-16:45
Title:Clinical Development of New Vaccines Phase I and II Trial; Manufacture Perspective in Developing Country Dr.Novilia Sjafri Bachtiar, Medical Doctor, Bio Farma, Indonesia
Dr. Charles M. Y. Lim, CEO Asia Pacific & China, BIA Separations, Austria
Co-Chair:
Dr. Niels Guldager, Senior Technology Partner, NNE Pharmaplan, Denmark
13:30-13:55
Title: Vaccine Process and Product Development, From Research to Commercialization.Case Study- Tetravalent Adjuvanted Vaccine Development Dr. Mario Contorni, Head, Novartis Vaccine and Diagnostics, USA
13:55-14:20
Title: Viral Vaccine Production at Manufacturing Scale (1000 m2 Surface) into iCELLisTM Disposable Fixed-bed Reactor Mr. Jose Castillo, Global Director, Cell Culture Technologies, ATMI LifeSciences, Belgium
14:20-14:45
Title: The State-of-the-art Intelligent System Ideally Built for the Downstream Bioprocessing of Vaccine and Protein Therapeutics Dr. Michael Li, Vice President, RJ Bio Process (Suzhou) Ltd., China
14:45-15:10
Title: An Innovative Technology Designed for Large Macrobiomolecules such as Viruses and VLPs, to Accelerate the Development of Vaccines and Increase its Production Capacity and Quality Dr. Charles M. Y. Lim, CEO Asia Pacific & China, BIA Separations Co. Ltd., Austria
15:10-15:30
Coffee Break
15:30-15:55
Title: Speedy Developments of Sandwich ELISA Kits for Vaccine Development Dr. Le Sun, President & CEO, AbMax Biotechnology Co., China
15:55-16:20
Title: How to Design and Build Flexible Multi-product Vaccine Manufacturing Facilities at Affordable Cost and as �Fast Track� Dr. Niels Guldager, Senior Technology Partner, NNE Pharmaplan, Denmark
16:20-16:45
Title:Single Use Bioreactors for Vaccine Production Dr. Thorsten Michael Adams, Product Manager, Sartorius Stedim Biotech, Gemany
